PCN19 A LITERATURE REVIEW ON THE CLINICAL AND ECONOMIC OUTCOMES ATTRIBUTABLE TO FIRST-LINE TREATMENT FOR CHRONIC MYELOID LEUKAEMIA (CML) WITH IMATINIB MESYLATE AND BONE MARROW TRANSPLANTATION (BMT)
Oct 1, 2009, 00:00
10.1016/S1098-3015(10)74271-6
https://www.valueinhealthjournal.com/article/S1098-3015(10)74271-6/fulltext
Title :
PCN19 A LITERATURE REVIEW ON THE CLINICAL AND ECONOMIC OUTCOMES ATTRIBUTABLE TO FIRST-LINE TREATMENT FOR CHRONIC MYELOID LEUKAEMIA (CML) WITH IMATINIB MESYLATE AND BONE MARROW TRANSPLANTATION (BMT)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)74271-6&doi=10.1016/S1098-3015(10)74271-6
First page :
Section Title :
Open access? :
No
Section Order :
197